Live Breaking News & Updates on Kalvista Pharmaceuticals Trading

Stay updated with breaking news from Kalvista pharmaceuticals trading. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

KalVista Pharmaceuticals (NASDAQ:KALV) Receives "Buy" Rating from Needham & Company LLC

KalVista Pharmaceuticals (NASDAQ:KALV) Receives "Buy" Rating from Needham & Company LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Benjaminl Palleiko , Edwardp Feener , Institutional Investors Weigh In On Kalvista Pharmaceuticals , Needham Company , Kalvista Pharmaceuticals Inc , Frazier Life Sciences Management , Vanguard Group Inc , Kalvista Pharmaceuticals Trading , Affinity Asset Advisors , Securities Exchange Commission , News Ratings For Kalvista Pharmaceuticals Daily , Nan Fung Group Holdings Ltd , Kalvista Pharmaceuticals , Sg Americas Securities , Free Report , Vista Pharmaceuticals , Get Free Report , Exchange Commission , Asset Advisors , Fung Group Holdings Ltd , Kalvista Pharmaceuticals Daily ,

KalVista Pharmaceuticals (NASDAQ:KALV) Stock Price Up 6.8%

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report)’s stock price was up 6.8% on Wednesday . The stock traded as high as $12.13 and last traded at $12.12. Approximately 71,232 shares were traded during trading, a decline of 90% from the average daily volume of 700,371 shares. The stock had previously closed at $11.35. Analyst […] ....

United States , Benjaminl Palleiko , Thomas Andrew Crockett , Frazier Life Sciences Management , Affinity Asset Advisors , News Ratings For Kalvista Pharmaceuticals Daily , Kalvista Pharmaceuticals Trading , Institutional Trading Of Kalvista Pharmaceuticals , Needham Company , Kalvista Pharmaceuticals Company Profile , Nan Fung Group Holdings Ltd , Kalvista Pharmaceuticals , Sg Americas Securities , Vanguard Group Inc , Kalvista Pharmaceuticals Inc , Get Free Report , Vista Pharmaceuticals , Andrew Crockett , Asset Advisors , Fung Group Holdings Ltd , Kalvista Pharmaceuticals Daily ,

Insider Buying: KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Major Shareholder Buys $54,178.52 in Stock

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par bought 4,174 shares of the business’s stock in a transaction on Friday, January 26th. The stock was purchased at an average cost of $12.98 per share, for a total transaction of $54,178.52. Following the transaction, the insider now owns 4,569,984 shares […] ....

United States , Metlife Investment Management , Kalvista Pharmaceuticals , Kalvista Pharmaceuticals Inc , News Ratings For Kalvista Pharmaceuticals Daily , Kalvista Pharmaceuticals Trading , Kalvista Pharmaceuticals Company Profile , York Mellon Corp , Blackrock Inc , Quarter For Kalvista Pharmaceuticals , Hedge Funds Weigh In On Kalvista Pharmaceuticals , Securities Exchange Commission , Jpmorgan Chase Co , Get Free Report , Venrock Healthcare Capital Par , Exchange Commission , Healthcare Capital Par , Vista Pharmaceuticals , New York Mellon Corp , Life Investment Management , Kalvista Pharmaceuticals Daily , Nasdaq Kalv , Insider Trading , Nsider Trades ,

Prosight Management LP Sells 381,667 Shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV)

Prosight Management LP cut its holdings in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Free Report) by 61.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 240,000 shares of the specialty pharmaceutical company’s stock after selling 381,667 shares during the quarter. KalVista Pharmaceuticals comprises […] ....

Hong Kong , United States , Benjaminl Palleiko , Thomas Andrew Crockett , Kalvista Pharmaceuticals Company Profile , Kalvista Pharmaceuticals , Kalvista Pharmaceuticals Inc , Kalvista Pharmaceuticals Trading , Securities Exchange Commission , News Ratings For Kalvista Pharmaceuticals Daily , Barclays Plc , Hong Kong Ltd , Quarter For Kalvista Pharmaceuticals , Cantor Fitzgerald , Prosight Management , Free Report , Vista Pharmaceuticals , Kong Ltd , Andrew Crockett , Exchange Commission , Get Free Report , Visit Holdingschannel , Kalvista Pharmaceuticals Daily , Nasdaq Kalv , Sec Filings , Hedge Fund Holdings ,

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) CFO Benjamin L. Palleiko Sells 4,037 Shares of Stock

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Rating) CFO Benjamin L. Palleiko sold 4,037 shares of the stock in a transaction on Thursday, May 18th. The shares were sold at an average price of $10.14, for a total value of $40,935.18. Following the sale, the chief financial officer now directly owns 78,126 shares in the company, […] ....

New York , United States , Benjaminl Palleiko , Kalvista Pharmaceuticals Company Profile , Kalvista Pharmaceuticals Inc , First Manhattan , Cantor Fitzgerald , Quarter For Kalvista Pharmaceuticals , Needham Company , Saturnv Capital Management , Kalvista Pharmaceuticals , Squarepoint Ops , Kalvista Pharmaceuticals Trading , Securities Exchange Commission , Jpmorgan Chase Co , News Ratings For Kalvista Pharmaceuticals Daily , Get Rating , Exchange Commission , Vista Pharmaceuticals , Street Corp , Kalvista Pharmaceuticals Daily , Nasdaq Kalv , Insider Trading , Nsider Trades ,